Valérie Leroy
Investor Relations Contact bij VALERIO THERAPEUTICS
Profiel
Valérie Leroy is currently the Director-Investor Relations & Communications at Valerio Therapeutics SA since 2016.
Prior to this, she worked as the Director-Marketing & Investor Relations at Carmat SA and as the Head-Investor Relations & Corporate Communications at Genticel SA. Ms. Leroy graduated from the Institut d'Administration des Entreprises de Paris in 1996.
Actieve functies van Valérie Leroy
| Bedrijven | Functie | Begin |
|---|---|---|
| VALERIO THERAPEUTICS | Investor Relations Contact | 01-12-2016 |
Eerdere bekende functies van Valérie Leroy
| Bedrijven | Functie | Einde |
|---|---|---|
Genticel SA
 Genticel SA BiotechnologyHealth Technology Genticel SA operates as a clinical stage biotechnology company, which focuses on the development of immunotherapies designed to fight infectious diseases and cancer. The company was founded by Bénédikt Timmerman and Ludovic de Meeus d'Argenteuil on October 15, 2001 and is headquartered in Labège, France. | Investor Relations Contact | - |
| CARMAT | Investor Relations Contact | - |
Opleiding van Valérie Leroy
| Institut d'Administration des Entreprises de Paris | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| VALERIO THERAPEUTICS | Health Technology |
| CARMAT | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genticel SA
Genticel SA BiotechnologyHealth Technology Genticel SA operates as a clinical stage biotechnology company, which focuses on the development of immunotherapies designed to fight infectious diseases and cancer. The company was founded by Bénédikt Timmerman and Ludovic de Meeus d'Argenteuil on October 15, 2001 and is headquartered in Labège, France. | Health Technology |
